University of Chicago

Argonne and other institutions report first-ever atomic freeze frame of liquid water

Retrieved on: 
Friday, February 16, 2024
White House, Federal Government, Aerospace, Energy, Manufacturing, Technology, University, Radiology, Nuclear, Education, Public Policy, Government, Other Technology, Science, Other Science, Other Energy, Research, Health, Pacific Northwest National Laboratory, Electron, Nobel Prize in Physics, University of Chicago, James Franck Institute, Radiation, Argonne National Laboratory, Void coefficient, SLAC National Accelerator Laboratory, History, University of Washington, Movement, Washington State University, Nobel Prize

Their study, recently published in the journal Science , built on the new science of attosecond physics, recognized with the 2023 Nobel Prize in Physics.

Key Points: 
  • Their study, recently published in the journal Science , built on the new science of attosecond physics, recognized with the 2023 Nobel Prize in Physics.
  • The study sample was a stream of liquid water, chosen as a model molecule in this first-ever experiment.
  • This allowed them to take a fingerprint of the electronic response following ionization in liquid water, all before the bulkier hydrogen atoms have time to move.
  • The findings demonstrate that a longstanding measurement of the structure of liquid water has been misinterpreted.

Innovate Illinois Celebrates NSF's Award to Propel Great Lakes ReNew and Advance Water Innovation

Retrieved on: 
Friday, February 2, 2024
Utilities, Environmental Policy, Public Policy, Government, Environmental Health, Energy, Other Natural Resources, Environment, Sustainability, White House, Federal Government, Natural Resources, Green Technology, State, Local, Climate Change, Nitrate, Principal, Public, Innovation, Science, University of Chicago, Blue, STEM, University, Climate change, Water, University of Illinois Urbana-Champaign, Engineering, Carbon, PFAS, Investment, Nutrient, Argonne National Laboratory, Pritzker School, NSF, ReNEW Schools, Great Lakes region, Health, Phosphate, Face, Renewable energy

Innovate Illinois , a pioneering public-private coalition dedicated to bolstering state innovation, celebrates the substantial federal award granted to the Great Lakes Water Innovation Engine, also known as Great Lakes ReNew .

Key Points: 
  • Innovate Illinois , a pioneering public-private coalition dedicated to bolstering state innovation, celebrates the substantial federal award granted to the Great Lakes Water Innovation Engine, also known as Great Lakes ReNew .
  • Great Lakes ReNew, directed by Current , Chicago's premier water innovation incubator, is positioned to revolutionize water and resource recovery.
  • The initiative aims to turn waste into wealth, exemplifying the mission of Innovate Illinois to foster economic growth through groundbreaking innovation.
  • “The Great Lakes are a vital natural resource for the health, wealth, and security of our entire nation,” said Illinois Gov.

The Banks Law Firm Welcomes Jesse Rigsby as its Newest Principal

Retrieved on: 
Wednesday, January 24, 2024
Philosophy, Journal, Employment, Vanderbilt University, Social science, Order of the Coif, University of Chicago, University, Personal injury, Lund University, Phi Beta Kappa, LLM

Durham, North Carolina, USA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Banks Law Firm, P.A .

Key Points: 
  • Durham, North Carolina, USA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Banks Law Firm, P.A .
  • (“TBLF”) is excited to announce the promotion of Jesse Rigsby, IV to the position of Principal.
  • Mr. Rigsby primarily practices as a litigator focused on business, commercial, employment, and personal injury disputes.
  • We are excited to recognize him with this promotion to Principal for his contributions to TBLF and its clients” said Sherrod Banks, TBLF Founding Principal.

Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

Retrieved on: 
Monday, January 22, 2024
Schizophrenia, Patient, Therapy, Public policy, University of Chicago, University, Neuropsychiatry, DSM-IV codes, University of Wisconsin–Madison, Vortioxetine, Brain, MDD

WATERTOWN, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the appointment of Kaya Pai Panandiker as chief commercial officer and a member of Neumora’s executive team, reporting to Henry Gosebruch, president and chief executive officer.

Key Points: 
  • WATERTOWN, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the appointment of Kaya Pai Panandiker as chief commercial officer and a member of Neumora’s executive team, reporting to Henry Gosebruch, president and chief executive officer.
  • Ms. Pai Panandiker brings extensive commercial strategy and execution expertise to Neumora, having led the launches of multiple neuropsychiatry products throughout her career.
  • Prior to joining Neumora, Ms. Pai Panandiker served as head of commercial at Cerevel Therapeutics and general manager, neuroscience at Lundbeck US.
  • “It is an incredibly exciting time to join Neumora as we progress pivotal studies in MDD and advance a deep pipeline in schizophrenia, Alzheimer’s, Parkinson’s and other disease areas with significant unmet medical need,” said Kaya Pai Panandiker, chief commercial officer, Neumora.

CellVax Therapeutics Announces FDA Clearance of IND Application for FK-PC101, a Novel Personalized Cancer Immunotherapy

Retrieved on: 
Monday, January 29, 2024
Patient, Prostate cancer, Radiation, Partnership, Consultant, Society, University of Chicago, DFS, University, Principal investigator, Risk, Immunotherapy, Recurrence, IND, Food, ADT, MHC, FDA, Investigational New Drug, CDMO, CGMP, Clinical trial, Phase, Prostatectomy, Major histocompatibility complex, Pharmaceutical industry

FK-PC101 is CellVax's novel personalized cancer immunotherapy intended to treat prostate cancer patients who have a high risk of recurrence after prostatectomy.

Key Points: 
  • FK-PC101 is CellVax's novel personalized cancer immunotherapy intended to treat prostate cancer patients who have a high risk of recurrence after prostatectomy.
  • It consists of patient's own tumor cells which are collected during surgery, then modified in the laboratory.
  • Fernando Kreutz, CEO at CellVax, stated, "We are thrilled to receive FDA clearance of our FK-PC101 IND.
  • The trial, CELLVX-230, is a randomized, multicenter, open-label study of irradiated autologous cellular vaccine in men with high-risk prostate cancer post-radical prostatectomy.

Documentary Film "The Fight For Black Lives" To Premiere At SBIFF

Retrieved on: 
Tuesday, January 23, 2024
Social media, Health, Photography, Rush University, University of Chicago, University, Government, COVID-19, African Americans, Film industry

CHICAGO, Jan. 23, 2024 /PRNewswire-PRWeb/ -- The Fight For Black Lives documentary is premiering at the Santa Barbara International Film Festival in February. Directed by University of Chicago professor Dr. Micere Keels, the film explores racial health disparities, specifically examining how racial stress and the American healthcare system disadvantage the health of Black Americans.

Key Points: 
  • "The Fight For Black Lives" documentary is premiering at the Santa Barbara International Film Festival on February 11th & 13th, 2024
    CHICAGO, Jan. 23, 2024 /PRNewswire-PRWeb/ -- The Fight For Black Lives documentary is premiering at the Santa Barbara International Film Festival in February.
  • "I embarked on the journey of creating 'The Fight For Black Lives' with a commitment to uncovering deep-rooted injustices within our healthcare system and their impact on Black lives.
  • This documentary is as a powerful narrative of the urgent need for health justice in America," explains Dr.
  • "I embarked on the journey of creating 'The Fight For Black Lives' with a commitment to uncovering deep-rooted injustices within our healthcare system and their impact on Black lives.

College Cliffs Reveals Its List of The 20 Most Beautiful Chapels and Cathedrals on College Campuses

Retrieved on: 
Tuesday, January 23, 2024
University Chapel, Lee University, Stanford University, University, Cathedral, School, Rutgers University, Spirituality, University of Chicago, History, Religion, Wake Forest University, Resurrection, System, Tufts University, Lewis & Clark College, University of Florida, Stonemasonry

NASHVILLE, Tenn., Jan. 23, 2024 /PRNewswire/ -- Celebrating landmarks of historic aesthetic value, College Cliffs has identified the most stunning chapels and cathedrals on college campuses.

Key Points: 
  • NASHVILLE, Tenn., Jan. 23, 2024 /PRNewswire/ -- Celebrating landmarks of historic aesthetic value, College Cliffs has identified the most stunning chapels and cathedrals on college campuses.
  • Coming in behemoth sizes, the college cathedrals take us on a journey to European architectural arts.
  • The college chapels, in comparison, resemble smaller yet remarkable structures with interiors that are just as exquisite.
  • Our list was put together with beautiful design, rich history, and the popularity of the religious structures in mind.

Alphabet Inc Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 16, 2024
Software, Technology, Internet, Apps, Applications, Cloud, Google Maps, Research, Health, Collection, Android, University of Chicago, Gambling, University, Google Drive, Google Cloud Platform, Digital, Climate change, Investment, Alphabet Inc., Chrome, Transport, Google Cloud, Google Photos, Google Workspace, Gmail

This report provides insights into Alphabet's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Key Points: 
  • This report provides insights into Alphabet's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
  • Alphabet Inc (Alphabet) is a collection of businesses.
  • Its largest business is Google, which includes two segments: Google Services and Google Cloud.
  • Google Services' key platforms and products include Android, ads, Google Photos, Chrome, Google Maps, hardware, Gmail, Google Drive, Google Play, YouTube, and Search.

Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023

Retrieved on: 
Thursday, December 7, 2023
Associate, MMSc, Survival, Lymphoid leukemia, University of Antwerp, MD, Doctor of Philosophy, Galapagos NV, Euronext, Galápagos Islands, University, CLL, Oncology, PST, Patient, University of Chicago, Harvard Medical School, Clinical research, KOL, FACP, Management

Mechelen, Belgium; 6 December 2023, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will host a Key Opinion Leader (KOL) event during the 65th ASH Annual Meeting & Exposition in San Diego, CA, on Sunday, December 10, 2023, from 11:00 am PST to 12:30 pm PST.

Key Points: 
  • Mechelen, Belgium; 6 December 2023, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will host a Key Opinion Leader (KOL) event during the 65th ASH Annual Meeting & Exposition in San Diego, CA, on Sunday, December 10, 2023, from 11:00 am PST to 12:30 pm PST.
  • The in-person event will be held at the San Diego Marriott Gaslamp Quarter in the Presidio Ballroom B/C.
  • To register as an in-person attendee, please click here .
  • Galapagos leadership, including Paul Stoffels1, MD, CEO and Chairman, will provide updates on:
    A live question and answer will follow the formal presentations.

IN8bio to Host Investor Call at 8:30 AM ET on Tuesday, December 12 to Discuss Updated Clinical Data from Phase 1 Trial of INB-100 in Patients with Leukemia

Retrieved on: 
Tuesday, December 5, 2023
Conference, National Cancer Institute, MD, Society, Haematopoietic system, Transplant, Bone marrow, ASH, University, Annual general meeting, Bangladesh Technical Education Board, Webcast, HSCT, Patient, NCI, University of Chicago

The event will highlight data presented at the ASH 65th Annual Meeting in a poster presentation on December 11, 2023 starting at 6:00 pm PT.

Key Points: 
  • The event will highlight data presented at the ASH 65th Annual Meeting in a poster presentation on December 11, 2023 starting at 6:00 pm PT.
  • The Company’s INB-100 trial is focused on investigating the potential of harnessing donor-derived allogeneic gamma-delta T cells for the treatment of patients with hematological malignancies following hematopoietic bone marrow transplantation (HSCT).
  • Dr. Bishop is a prominent clinical investigator of acute leukemias, with a focus on improving transplant outcomes and preventing relapse.
  • IN8bio will host a conference call and webcast on Tuesday, December 12, 2023, at 8:30 am ET to review the updated data from the poster presentation at ASH.